Bloomberg the Company

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: New York
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Laboratory Corp of America Holdings

+ Add to Watchlist


116.4100 USD 0.1200 0.10%

As of 11:16:29 ET on 01/28/2015.

Snapshot for Laboratory Corp of America Holdings (LH)

Open: 116.5300 Day's Range: 116.0700 - 117.3500 Volume: 383,579
Previous Close: 116.2900 52wk Range: 87.2500 - 119.2100 1-Yr Rtn: +28.94%

Stock Chart for LH

No chart data available.
  • LH:US 116.4200
  • 1D
  • 1M
  • 1Y
Interactive LH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LH

Current P/E Ratio (ttm) 18.8019
Estimated P/E(12/2014) 17.1570
Relative P/E vs. SPX 1.0543
Earnings Per Share (USD) (ttm) 6.1850
Est. EPS (USD) (12/2014) 6.7780
Est. PEG Ratio 1.7014
Market Cap (M USD) 9,826.51
Shares Outstanding (M) 84.50
30 Day Average Volume 1,463,889
Price/Book (mrq) 3.5675
Price/Sale (ttm) 1.6814
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LH

Laboratory Corporation of America Holdings is a clinical laboratory company that offers clinical laboratory tests used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. The Company develops specialty testing operations, such as oncology testing, HIV genotyping and phenotyping, diagnostic genetics and clinical trials.

David P KingChairman/President/CEOGlenn A EisenbergExec VP/CFO
James T Boyle JrExec VP/COOMark Elliott BrecherSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for LH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
  • LH News

  • Industry News

Sponsored Links
sec ||= nil